Items where Author is "Brooke, Greg N"

Article

Jacob, Divya R and Guiblet, Wilfried M and Mamayusupova, Hulkar and Shtumpf, Mariya and Ciuta, Isabella and Ruje, Luminita and Gretton, Svetlana and Bikova, Milena and Correa, Clark and Dellow, Emily and Agrawal, Shivam P and Shafiei, Navid and Drobysevskaja, Anastasija and Armstrong, Chris M and Lam, Jonathan DG and Vainshtein, Yevhen and Clarkson, Christopher T and Thorn, Graeme J and Sohn, Kai and Pradeepa, Madapura M and Chandrasekharan, Sankaran and Brooke, Greg N and Klenova, Elena and Zhurkin, Victor B and Teif, Vladimir B (2024) Nucleosome reorganisation in breast cancer tissues. Clinical Epigenetics, 16 (1). 50-. DOI https://doi.org/10.1186/s13148-024-01656-4

Pine, Angela C and Brooke, Greg N and Marco, Antonio (2023) A computational approach to identify efficient RNA cleaving 10-23 DNAzymes. NAR Genomics and Bioinformatics, 5 (1). lqac098-. DOI https://doi.org/10.1093/nargab/lqac098

Alghamdi, Rana A and Exposito-Rodriguez, Marino and Mullineaux, Philip M and Brooke, Greg N and Laissue, Philippe P (2021) Assessing Phototoxicity in a Mammalian Cell Line: How Low Levels of Blue Light Affect Motility in PC3 Cells. Frontiers in Cell and Developmental Biology, 9. 738786-. DOI https://doi.org/10.3389/fcell.2021.738786

Leach, Damien A and Brooke, Greg N and Bevan, Charlotte L (2021) Roles of steroid receptors in the lung and COVID-19. Essays in Biochemistry, 65 (6). pp. 1025-1038. DOI https://doi.org/10.1042/ebc20210005

Cronin, Ryan and Brooke, Greg N and Prischi, Filippo (2021) The role of the p90 ribosomal S6 kinase family in prostate cancer progression and therapy resistance. Oncogene, 40 (22). pp. 3775-3785. DOI https://doi.org/10.1038/s41388-021-01810-9

Brooke, Greg N and Prischi, Filippo (2020) Structural and functional modelling of SARS-CoV-2 entry in animal models. Scientific Reports, 10 (1). 15917-. DOI https://doi.org/10.1038/s41598-020-72528-z

Mohr, Andrea and Chu, Tianyuan and Brooke, Greg N and Zwacka, Ralf M (2019) MSC.sTRAIL Has Better Efficacy than MSC.FL-TRAIL and in Combination with AKTi Blocks Pro-Metastatic Cytokine Production in Prostate Cancer Cells. Cancers, 11 (4). p. 568. DOI https://doi.org/10.3390/cancers11040568

Pine, Angela C and Fioretti, Flavia F and Brooke, Greg N and Bevan, Charlotte L (2016) Advances in genetics: widening our understanding of prostate cancer. F1000Research, 5. p. 1512. DOI https://doi.org/10.12688/f1000research.8019.1

Brooke, Greg N and Gamble, Simon C and Hough, Michael A and Begum, Shajna and Dart, D Alwyn and Odontiadis, Michael and Powell, Sue M and Fioretti, Flavia M and Bryan, Rosie A and Waxman, Jonathan and Wait, Robin and Bevan, Charlotte L (2015) Antiandrogens Act as Selective Androgen Receptor Modulators at the Proteome Level in Prostate Cancer Cells*. Molecular & Cellular Proteomics, 14 (5). pp. 1201-1216. DOI https://doi.org/10.1074/mcp.m113.036764

Querol Cano, Laia and Lavery, Derek N and Sin, Soraya and Spanjaard, Emma and Brooke, Greg N and Tilman, Jessica D and Abroaf, Ahmed and Gaughan, Luke and Robson, Craig N and Heer, Rakesh and Mauri, Francesco and de Rooij, Johan and Driouch, Keltouma and Bevan, Charlotte L (2015) The co‐chaperone p23 promotes prostate cancer motility and metastasis. Molecular Oncology, 9 (1). pp. 295-308. DOI https://doi.org/10.1016/j.molonc.2014.08.014

Rudraraju, Bharath and Droog, Marjolein and Abdel-Fatah, Tarek MA and Zwart, Wilbert and Giannoudis, Athina and Malki, Mohammed I and Moore, David and Patel, Hetal and Shaw, Jacqui and Ellis, Ian O and Chan, Steve and Brooke, Greg N and Nevedomskaya, Ekaterina and Nigro, Christiana Lo and Carroll, Jason and Coombes, R Charles and Bevan, Charlotte and Ali, Simak and Palmieri, Carlo (2014) Phosphorylation of activating transcription factor-2 (ATF-2) within the activation domain is a key determinant of sensitivity to tamoxifen in breast cancer. Breast Cancer Research and Treatment, 147 (2). pp. 295-309. DOI https://doi.org/10.1007/s10549-014-3098-0

Brooke, Greg N and Powell, Sue M and Lavery, Derek N and Waxman, Jonathan and Buluwela, Laki and Ali, Simak and Bevan, Charlotte L (2014) Engineered repressors are potent inhibitors of androgen receptor activity. Oncotarget, 5 (4). pp. 959-969. DOI https://doi.org/10.18632/oncotarget.1360

Ottaviani, Silvia and Brooke, Greg N and O'Hanlon-Brown, Ciara and Waxman, Jonathan and Ali, Simak and Buluwela, Laki (2013) Characterisation of the androgen regulation of glycine N-methyltransferase in prostate cancer cells. Journal of Molecular Endocrinology, 51 (3). pp. 301-312. DOI https://doi.org/10.1530/jme-13-0169

Sita-Lumsden, Ailsa and Fletcher, Claire E and Dart, D Alwyn and Brooke, Greg N and Waxman, Jonathan and Bevan, Charlotte L (2013) Circulating nucleic acids as biomarkers of prostate cancer. Biomarkers in Medicine, 7 (6). pp. 867-877. DOI https://doi.org/10.2217/bmm.13.104

Reebye, Vikash and Querol Cano, Laia and Lavery, Derek N and Brooke, Greg N and Powell, Sue M and Chotai, Deepa and Walker, Marjorie M and Whitaker, Hayley C and Wait, Robin and Hurst, Helen C and Bevan, Charlotte L (2012) Role of the HSP90-Associated Cochaperone p23 in Enhancing Activity of the Androgen Receptor and Significance for Prostate Cancer. Molecular Endocrinology, 26 (10). pp. 1694-1706. DOI https://doi.org/10.1210/me.2012-1056

Brooke, Greg N and Culley, Rachel L and Dart, D Alwyn and Mann, David J and Gaughan, Luke and McCracken, Stuart R and Robson, Craig N and Spencer-Dene, Bradley and Gamble, Simon C and Powell, Sue M and Wait, Robin and Waxman, Jonathan and Walker, Marjorie M and Bevan, Charlotte L (2011) FUS/TLS Is a Novel Mediator of Androgen-Dependent Cell-Cycle Progression and Prostate Cancer Growth. Cancer Research, 71 (3). pp. 914-924. DOI https://doi.org/10.1158/0008-5472.can-10-0874